AI brief of an SEC Form 8-K · LEE ENTERPRISES, Inc (LEE)

Lee Enterprises appoints Gregory Hoffmann to board, effective immediately

Neutral Impact 3 of 5 leadership Written later

Lee Enterprises appointed Gregory Hoffmann, age 37, as a director effective immediately, with a term running until its 2028 annual meeting, and placed him on the Nominating and Corporate Governance Committee. The filing discloses that he is the son of Chairman and majority stockholder David Hoffmann, and it lists related-party dealings between the company and the Hoffmann family, including a management agreement with Hoffmann Media Group. The filing reports no financial results, so the change is governance-related rather than a measure of operating performance.

Key points

  • Board appointment made September 24, 2026; announced in a press release dated September 30, 2026
  • Gregory Hoffmann serves as Co-Chief Executive Officer of Hoffmann Family of Companies and has been CEO of Hoffmann Commercial Real Estate since April 2017
  • He is the son of David Hoffmann, Chairman and majority stockholder, who bought 10,909,440 shares in a February 5, 2026 private placement
  • Hoffmann Media Group pays a fixed management fee of $135,000 per fiscal quarter under a May 14, 2026 five-year agreement

The filing

CompanyLEE ENTERPRISES, Inc (LEE)
Form8-K, current report
Filed with the SECSep 30, 2026, 9:55 AM ET
Accession number0000058361-26-000071

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 30, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.